NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

It's not a new narrative, it's an existing narrative that has already been proven true.

DCVax-L has been available as a treatment, commercially, in the UK for over a year now.

Why aren't GBM patients flooding in from all around the globe to receive treatment?

I will answer that. The reason is that a medical doctor in lets say Switzerland or Norway will pay so much more attention to a cancer drug that can save a life and is regulated in the UK than a medical drug that is simply not regulated with an RA with repute such as the FDA, MHRA or EMA. Any MD will tell you that as such is a world of difference. So yeah after UK approval patients who can afford DCVAXL all over the globe will be directed to the UK by their MD.